ATCC Announces Creation of Biomaterial Contributor Network
ATCC creates Biomaterial Contributor Network to assist the research community.
ATCC
, a biological materials resource and standards organization, announces material deposit agreements with more than 30 public and private institutions. These institutions will have the option to participate in the biomaterial contributor network (BCN), and make research materials available to the research community. ATCC will coordinate with technology transfer offices at each institution to create a process for adding microbial strains and cell lines to the ATCC collection. Participants will have an opportunity to receive a share of the revenue from the sale and licensing of materials developed at their institutions. Over 225 biological materials are deposited under these agreements to date, with most available to both contributors and others as determined jointly by ATCC and the institution.
Source:
ATCC
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
